You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 7,482,024

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,482,024

Title:	Compositions comprising an active agent
Abstract:	The present invention provides a highly dispersible formulation comprising an active agent and a dipeptide or tripeptide comprising at least two leucyl residues. The composition of the invention possesses superior aerosol properties and is thus preferred for aerosolized administration to the lung. Also provided are a method for (i) increasing the dispersibility of an active-agent containing formulation for administration to the lung, and (ii) delivery of the composition to the lungs of a subject.
Inventor(s):	Kuo; Mei-chang (Palo Alto, CA), Lechuga-Ballesteros; David (San Jose, CA)
Assignee:	Nektar Therapeutics (San Carlos, CA)
Application Number:	10/985,509
Patent Claims:	1. A powder composition comprising an active agent and a dipeptide or tripeptide comprised of at least two leucines, wherein about a 0.2% aqueous solution of the di- or tri-peptide is capable of reducing a surface tension of said solution to about 60 mN/m or less, as measured after about 49 seconds, wherein the composition comprises particles having an MMD of less than about 10 microns, and wherein the active agent is not follicle stimulating hormone. 2. The composition of claim 1, in aerosolized form. 3. The composition of claim 1, further comprising a propellant. 4. The composition of claim 3, wherein the propellant is selected from the group consisting of a chlorofluorocarbon, a fluorocarbon, and combinations thereof. 5. The composition of claim 4, wherein the propellant comprises a chlorofluorocarbon or fluorocarbon. 6. The composition of claim 1, wherein the composition is suitable for delivery to the lung or deep lung by inhalation. 7. The composition of claim 1, wherein the di- or tripeptide is present in the composition from about 1% by weight to about 99% by weight. 8. The composition of claim 7, wherein the di- or tripeptide is present in the composition from about 2% by weight to about 75% by weight. 9. The composition of claim 8, wherein the di- or tripeptide is present in the composition from about 5% by weight to about 50% by weight. 10. The composition of claim 1, further comprising a pharmaceutically acceptable excipient or carrier. 11. The composition of claim 10, wherein the excipient is selected from the group consisting of carbohydrates, amino acids, peptides, proteins, organic acid salts, and polymers. 12. The composition of claim 1, comprising a dipeptide. 13. The composition of claim 1, comprising a tripepticie. 14. The composition of claim 13, wherein the tripeptide is selected from the group consisting of leu-leu-gly, leu-leu-ala, leu-leu-val, leu-leu-leu, leu-leu-ile, leu-leu-met, leu-leu-pro, leu-leu-phe, leu-leu-trp, leu-leu-ser, leu-leu-thr, leu-leu-cys, leu-leu-tyr, leu-leu-asp, leu-leu-glu, leu-leu-lys, leu-leu-arg, leu-leu-his, leu-leu-nor, leu-gly-leu, leu-ala-leu, leu-val-leu, leu-ile-leu, leu-met-leu, leu-pro-leu, leu-phe-leu, leu-trp-leu, leu-ser-leu, leu-thr-leu, leu-cys-leu, leu-tyr-leu, leu-asp-leu, leu-glu-leu, leu-lys-leu, leu-arg-leu, leu-nor-leu, and combinations thereof. 15. The composition of claim 14, wherein the tripeptide is trileucine. 16. The composition of claim 1, wherein said active agent is selected from the group consisting of amikacin, tobramycin, gentamicin, vancomycin, ciprofloxacin, levofloxacin, polymixin, Dnase, insulin, cyclosporin, parathyroid hormone, VLA-4 inhibitors, interleukin-4R, thrombopoletin, c-peptide, amylin, pro-insulin, interleukin-1, interleukin-2, alpha-1-antitrypsin, budesonide, human growth hormone, growth hormone releasing hormone, interferon alpha, interferon beta, growth colony stimulating factor, keratinocyte growth factor, glial growth factor, tumor necrosis factor, leutinizing hormone releasing hormone, calcitonin, low molecular weight heparin, somatostatin, respiratory syncytial virus antibody, erythropoietin, Factor VIII, Factor IX, ceredase, cerezyme and analogues, agonists and antagonists thereof. 17. The composition of claim 1, wherein the dry powder is a spray-dried powder. 18. The composition of claim 15, wherein said active agent comprises a biologically active fragment or analog of parathymid hormone. 19. The composition of claim 16, wherein said active agent comprises a biologically active fragment or analog of parathyroid hormone.

Details for Patent 7,482,024

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genzyme Corporation	CEREZYME	imiglucerase	For Injection	020367	05/23/1994	⤷ Try a Trial	2019-10-29
Genzyme Corporation	CEREZYME	imiglucerase	For Injection	020367	09/22/1999	⤷ Try a Trial	2019-10-29
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015	⤷ Try a Trial	2019-10-29
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.